Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
HE Broxmeyer - Journal of Experimental Medicine, 2013 - rupress.org
Erythropoietin (EPO), a humoral regulator of erythropoiesis and replacement therapy for
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
HE Broxmeyer - The Journal of experimental medicine, 2013 - pubmed.ncbi.nlm.nih.gov
Erythropoietin (EPO), a humoral regulator of erythropoiesis and replacement therapy for
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
[PDF][PDF] Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
HE Broxmeyer - J. Exp. Med, 2013 - pdfs.semanticscholar.org
© 2013 Broxmeyer This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration.
HE Broxmeyer - The Journal of Experimental Medicine, 2013 - europepmc.org
Erythropoietin (EPO), a humoral regulator of erythropoiesis and replacement therapy for
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
[PDF][PDF] Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
HE Broxmeyer - J. Exp. Med, 2013 - cyberleninka.org
© 2013 Broxmeyer This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the …
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
HE Broxmeyer - Journal of Experimental Medicine, 2013 - cir.nii.ac.jp
抄録< jats: p> Erythropoietin (EPO), a humoral regulator of erythropoiesis and replacement
therapy for selected red blood cell disorders in EPO-deficient patients, has been implicated …
therapy for selected red blood cell disorders in EPO-deficient patients, has been implicated …
[HTML][HTML] Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
HE Broxmeyer - The Journal of Experimental Medicine, 2013 - ncbi.nlm.nih.gov
Erythropoietin (EPO), a humoral regulator of erythropoiesis and replacement therapy for
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …
selected red blood cell disorders in EPO-deficient patients, has been implicated in a wide …